Professor | Zou Zhengyun | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Zou Zhengyun
Contact Information	zouzhengyun001@163.com
Language ability	English, Chinese, French
Province	Jiangsu

Upload Avatar (500 x 500)

Name

Zou Zhengyun

Contact Information

zouzhengyun001@163.com

Language ability

English, Chinese, French

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Medical School
Academic Background & Achievements	Medical Doctor: Nanjing University Medical School Visiting Scholar: University of Texas Health Science Center at Houston Visiting Scholar: Paul Brousse Hospital, Paris Special Reviewer: Chinese Journal of Cancer Biotherapy Editorial Board Member: Journal of Tumor Nutrition and Metabolism Editorial Board Member: CSCO Malignant Melanoma Diagnosis and Treatment Guidelines 2019 First Reviewer: National Natural Science Foundation of China
Work Experience	Current - Nanjing University Medical School Affiliated Drum Tower Hospital - Chief Physician, Associate Professor, Doctoral Supervisor Current - Nanjing Drum Tower Hospital Jiangbei International Hospital - Director of Comprehensive Office Current - Nanjing University Medical School Affiliated Drum Tower Hospital - Deputy Director of Oncology Center Current - Nanjing University Medical School Affiliated Drum Tower Hospital - Head of Biological Therapy Group Current - Nanjing University Medical School Affiliated Drum Tower Hospital - Leader of Subspecialty in Malignant Melanoma and Hepatobiliary and Pancreatic Cancer
Awards	Jiangsu Province Medical New Technology Introduction First Prize (2017) Ministry of Education Science and Technology Progress Award Second Prize (2016) Jiangsu Province Science and Technology Award Second Prize (2015) Chinese Medical Science and Technology Award Third Prize (2015) Jiangsu Medical Science and Technology Award Second Prize (2015)

University/Lab Affiliation and Title

Nanjing University

Faculty

Medical School

Academic Background & Achievements

Medical Doctor: Nanjing University Medical School
Visiting Scholar: University of Texas Health Science Center at Houston
Visiting Scholar: Paul Brousse Hospital, Paris
Special Reviewer: Chinese Journal of Cancer Biotherapy
Editorial Board Member: Journal of Tumor Nutrition and Metabolism
Editorial Board Member: CSCO Malignant Melanoma Diagnosis and Treatment Guidelines 2019
First Reviewer: National Natural Science Foundation of China

Work Experience

Current - Nanjing University Medical School Affiliated Drum Tower Hospital - Chief Physician, Associate Professor, Doctoral Supervisor
Current - Nanjing Drum Tower Hospital Jiangbei International Hospital - Director of Comprehensive Office
Current - Nanjing University Medical School Affiliated Drum Tower Hospital - Deputy Director of Oncology Center
Current - Nanjing University Medical School Affiliated Drum Tower Hospital - Head of Biological Therapy Group
Current - Nanjing University Medical School Affiliated Drum Tower Hospital - Leader of Subspecialty in Malignant Melanoma and Hepatobiliary and Pancreatic Cancer

Awards

Jiangsu Province Medical New Technology Introduction First Prize (2017)
Ministry of Education Science and Technology Progress Award Second Prize (2016)
Jiangsu Province Science and Technology Award Second Prize (2015)
Chinese Medical Science and Technology Award Third Prize (2015)
Jiangsu Medical Science and Technology Award Second Prize (2015)

Areas of Focus	Precision Immunotherapy for Malignant Tumors Basic and Clinical Research on Malignant Melanoma
Publications	The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive cases, Corresponding Author, 2019 iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer, Co-First Author, 2019 Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors, Co-First Author, 2019 CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer, Co-First Author, 2016 Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma, Co-First Author, 2017 The plasma levels of 12 cytokines and growth factors in patients with gastric cancer, First Author, 2018 Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer, Co-First Author, 2018 Multidisciplinary collaboration in gallbladder carcinoma treatment: A case report and literature review, First Author, 2016 Gastric metastasis from sphenoid sinus melanoma: A case report, Corresponding Author, 2015

Areas of Focus

Precision Immunotherapy for Malignant Tumors
Basic and Clinical Research on Malignant Melanoma

Publications

The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive cases, Corresponding Author, 2019
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer, Co-First Author, 2019
Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors, Co-First Author, 2019
CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer, Co-First Author, 2016
Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma, Co-First Author, 2017
The plasma levels of 12 cytokines and growth factors in patients with gastric cancer, First Author, 2018
Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer, Co-First Author, 2018
Multidisciplinary collaboration in gallbladder carcinoma treatment: A case report and literature review, First Author, 2016
Gastric metastasis from sphenoid sinus melanoma: A case report, Corresponding Author, 2015

Immunotherapy Malignant Tumors Precision Medicine Melanoma Clinical Research Biological Therapy T Cells Pd-1 Gene Neoantigen Cancer Treatment

Bing Chen - Nanjing University

Xu Yang - Southern University of Science and Technology

Qingyun Wang - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us